Inhibikase Shares Interim 3-Month Toxicology Studies Data Of Parkinson's Candidate
October 04, 2021 at 09:57 AM EDT
Inhibikase Therapeutics Inc(NASDAQ: IKT) hasannounced interim three-month resultsfrom its ongoing chronic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.